The hexosamine biosynthesis inhibitor azaserine prevents endothelial inflammation and dysfunction under hyperglycemic condition through antioxidant effects

MLA

Rajapakse, Angana Gupta, et al. “The Hexosamine Biosynthesis Inhibitor Azaserine Prevents Endothelial Inflammation and Dysfunction under Hyperglycemic Condition through Antioxidant Effects.” The American Journal of Physiology, vol. 296, no. 3, Mar. 2009, p. H815. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.195981671&authtype=sso&custid=ns315887.

APA

Rajapakse, A. G., Ming, X.-F., Carvas, J. M., & Yang, Z. (2009). The hexosamine biosynthesis inhibitor azaserine prevents endothelial inflammation and dysfunction under hyperglycemic condition through antioxidant effects. The American Journal of Physiology, 296(3), H815.

Chicago

Rajapakse, Angana Gupta, Xiu-Fen Ming, Joao M. Carvas, and Zhihong Yang. 2009. “The Hexosamine Biosynthesis Inhibitor Azaserine Prevents Endothelial Inflammation and Dysfunction under Hyperglycemic Condition through Antioxidant Effects.” The American Journal of Physiology 296 (3): H815. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.195981671&authtype=sso&custid=ns315887.